NAMI

NIMH-funded studies emphasize need for more research on depression, open access to medication

Published in Hospital and Nursing Home Week, April 20th, 2006

The National Alliance on Mental Illness (NAMI) has issued a statement by Michael Fitzpatrick, executive director, on study results in the New England Journal of Medicine on the treatment of major depression that are important to consumers, families and physicians.

Funded by the National Institute of Mental Health (NIMH), the studies represent the second level of the Sequenced Treatment Alternatives to Relieve Depression trials (STAR*D2), providing long-term, "real world," comparative evidence that treatment with medication works for the most treatment-resistant depression.

"STAR*D2 sends a clear message of hope to the 15 to 20 percent of...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hospital and Nursing Home Week

Source: Hospital and Nursing Home Week (2006-04-20)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry